In melanoma, IL‐33 seems to act on macrophages promoting the transition from the M1 to M2 subtype, thus protecting melanoma cells from killing mediated by tumor‐infiltrating lymphocytes (TILs) and promoting metastatic processes through the production of high levels of MMP‐9.86 Here, IL33 is linked to neoplasm.